Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-agonists of the GLP-1 and amylin receptors

Co-agonists of the GLP-1 and amylin receptors

US Patent 12054528 · Granted Aug 6, 2024

Estimated economic value: $208,108,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-sensitive albumin-binding derivatives2025
Amylin receptor agonists2024
Glucose-sensitive albumin-binding derivatives2023
Glucose sensitive insulins and uses thereof2023
Glucose-sensitive albumin-binding derivatives2021
Double-acylated GLP-1 derivatives2021
Double-acylated GLP-1 derivatives2021
GLP-1/glucagon receptor co-agonists for medical use2020
Amylin and calcitonin receptor agonist2019
Double-acylated GLP-1 derivatives2018
Stable GLP-1 based GLP-1/glucagon receptor co-agonists2018
Stable glucagon analogues and use for treatment of hypoglycaemia2018